Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  2001-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V98.10.2900PMID 11698269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis

  2001cited by this paper
• Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.

  2001influential reference
• Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.

  2001cited by this paper
• Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases

  2001cited by this paper
• Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

  2000cited by this paper
• Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.

  2000cited by this paper
• Incidence of acute and chronic GVHD after allogeneic peripheral blood stem cell and bone marrow transplantation: A meta-analysis

  2000cited by this paper
• Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients.

  2000cited by this paper
• Granulocyte colony-stimulating factor mobilization alters dendritic cell cytokine production and initiates T helper 2 polarization prior to host alloantigen presentation.

  2000cited by this paper
• Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle.

  2000cited by this paper
• Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation.

  2000cited by this paper
• Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial.

  2000cited by this paper
• Transplantation tolerance induced by "mega dose" CD34+ cell transplants.

  2000cited by this paper
• Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation.

  2000cited by this paper
• Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers.

  2000cited by this paper
• Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite.

  2000cited by this paper
• Introduction: TH2-inducing DC2 for immunotherapy.

  2000cited by this paper
• Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo1

  2000cited by this paper
• A randomised study of allogeneic transplantation with stem cells from blood or bone marrow

  2000cited by this paper
• Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor

  2000cited by this paper
• Innovations in allogeneic stem-cell transplantation.

  2000cited by this paper
• Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow.

  2000influential reference
• Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.

  2000cited by this paper
• Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience

  1999cited by this paper
• The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow.

  1999cited by this paper
• Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.

  1999cited by this paper
• Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte–colony‐stimulating factor

  1999cited by this paper
• Immune reconstitution following allogeneic peripheral blood stem cell transplants

  1999cited by this paper
• Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.

  1999cited by this paper
• Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products

  1999cited by this paper
• Mobilization of blood‐derived stem and progenitor cells in normal subjects by granulocyte‐macrophage‐ and granulocyte‐colony‐stimulating factors

  1999cited by this paper
• Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor.

  1999influential reference
• Reply

  1998cited by this paper
• Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.

  1998cited by this paper
• Stem Cell Biology for the Transfusionist

  1998cited by this paper
• Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells

  1998cited by this paper
• Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

  1998cited by this paper
• A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies

  1998cited by this paper
• Anaphylactoid reaction in a normal donor given granulocyte colony-stimulating factor.

  1998cited by this paper
• Acute gouty arthritis following recombinant human granulocyte colony-stimulating factor therapy in an allogeneic blood stem cell donor.

  1998cited by this paper
• TOLERANCE INDUCTION BY "MEGADOSE" HEMATOPOIETIC TRANSPLANTS

  1998cited by this paper
• Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells.

  1997cited by this paper
• Effect of the in vivo priming regimen for peripheral blood stem cells (PBSC) mobilization on in vitro generation of cytotoxic effectors by IL-2 activation of PBSC in a murine model

  1997cited by this paper
• Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.

  1997cited by this paper
• Mobilization kinetics of CD34+/Thy‐1dim progenitor cells during recombinant human granulocyte‐colony‐stimulating factor administration in normal donors

  1997cited by this paper
• The T cell response against fungal infections.

  1997cited by this paper
• Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections.

  1997cited by this paper
• Allogeneic blood stem cell transplantation: considerations for donors.

  1997influential reference
• Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow.

  1996cited by this paper
• Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks.

  1996cited by this paper
• Differential Expression of Telomerase Activity in Hematopoietic Progenitors from Adult Human Bone Marrow

  1996influential reference
• Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor.

  1996cited by this paper
• Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

  1996influential reference
• Granulocyte Colony-Stimulating Factor Downregulates Allogeneic Immune Responses by Posttranscriptional Inhibition of Tumor Necrosis Factor-α Production

  1996cited by this paper
• Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.

  1996cited by this paper
• Granulocyte colony‐stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes

  1995cited by this paper
• Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production.

  1995cited by this paper
• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

  1995cited by this paper
• Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.

  1995cited by this paper
• Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.

  1995cited by this paper
• Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program.

  1993cited by this paper
• The infusion of human fetal liver cells

  1993cited by this paper
• Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.

  1992cited by this paper
• Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry.

  1989cited by this paper
• Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.

  1989cited by this paper
• HLA associations with leukemia.

  1987cited by this paper
• Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity

  1984cited by this paper
• Major complications of marrow harvesting for transplantation.

  1983cited by this paper
• Major complications of marrow harvesting for transplantation.

  1983cited by this paper
• Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia.

  1981cited by this paper
• Technique for human marrow grafting.

  1970cited by this paper

• Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G‐CSF Treatment in Unrelated Donors

  2026cites this paper
• Transforming Medicine: Advances in Gene Therapy, Immunotherapy, and Targeted Cures.

  2025cites this paper
• Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children

  2025cites this paper
• GroβT rapidly and reliably mobilizes primitive hematopoietic stem and progenitor cells in nonhuman primates

  2025cites this paper
• Role of CD34 Count as a Prognostic Marker for Vascular Complications in Sickle Cell Disease

  2025cites this paper
• Use of AMD3100 for Bone Marrow Derived Mesenchymal Stem Cells Mobilization in the Treatment of Murine Asherman's Syndrome.

  2025cites this paper
• Comprehensive Phenotyping of Extracellular Vesicles in Plasma of Healthy Humans – Insights Into Cellular Origin and Biological Variation

  2025cites this paper
• Optimal ex vivo production of functional neutrophils is dependent on the source of CD34+ human hematopoietic progenitors.

  2025cites this paper
• Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT

  2025cites this paper
• Effects of Exosomes from Menstrual Blood-derived Stem Cells and Ginger on Endometriotic Stem Cells

  2024cites this paper
• Incidence and impact of invasive fungal infection comparing post-transplant cyclophosphamide with cyclosporine plus methotrexate GVHD prophylaxis in allogeneic HSCT.

  2024cites this paper
• Comprehensive Phenotyping of Extracellular Vesicles in Blood of Healthy Humans – Insights into Cellular Origin and Biological Variability

  2024influential citation
• Predicting apheresis yield and factors affecting peripheral blood stem cell harvesting using a machine learning model

  2024cites this paper
• Adipose-derived Mesenchymal Stem Cell Transplantation Improves Ovarian Function and Oocyte Quality in Aged Mice

  2024cites this paper
• Establishment of reference values based on influential characteristics of hematopoietic stem cells and immune cell subsets in the bone marrow

  2024cites this paper
• Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy.

  2023cites this paper
• The spatiotemporal heterogeneity of the biophysical microenvironment during hematopoietic stem cell development: from embryo to adult

  2023cites this paper
• Graft versus Leukemia in 2023.

  2023cites this paper
• Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy

  2023cites this paper
• The regulation mechanism of hematopoiesis during ischemic and hemolytic anemia in grass carp(Ctenopharyngodon idella)

  2023cites this paper
• Haploidentical hematopoietic stem cell transplantation in pediatric and adolescent patients: A study of the Spanish hematopoietic stem cell transplantation group (GETH).

  2022cites this paper
• Cell therapy for the treatment of reproductive diseases and infertility: an overview from the mechanism to the clinic alongside diagnostic methods

  2022cites this paper
• A topological refactoring design strategy yields highly stable granulopoietic proteins

  2022cites this paper
• The altered expression of homing factors in CD34+ hematopoietic stem cells following G‐CSF injection and its effects on transplantation quality in ALL patients

  2022influential citation
• Risk factors for adverse outcomes following haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: a two-center analysis

  2022cites this paper
• Stem cells: a comprehensive review of origins and emerging clinical roles in medical practice.

  2022cites this paper
• Comparison of clinical outcomes between peripheral blood stem cells and peripheral blood stem cells plus bone marrow in myelodysplastic syndrome patients with haploidentical transplantation

  2022cites this paper
• Immunologic recovery and basis for infections in the pediatric hematopoietic stem cell transplant recipient

  2021cites this paper
• Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors

  2021cites this paper
• Is Post-Transplant Cyclophosphamide the New Methotrexate?

  2021cites this paper
• Cell Therapy: Types, Regulation, and Clinical Benefits

  2021cites this paper
• Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities

  2021cites this paper
• Ex Vivo Manufacture of Megakaryocytes and Platelets from Stem Cells: Recent Advances Toward Transfusion in Humans

  2021influential citation
• Design of novel granulopoietic proteins by topological rescaffolding

  2020cites this paper
• Perinatal tissues and cells in tissue engineering and regenerative medicine.

  2020cites this paper
• The Prospect of Stem Cells for HIV and Cancer Treatment: A Review

  2020cites this paper
• Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation

  2020cites this paper
• Hematopoietic Stem Cell Transplantation and Lymphodepletion for the Treatment of Cancer

  2020cites this paper
• A profile of circulating vascular progenitor cells in human neovascular age-related macular degeneration

  2020cites this paper
• Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programs.

  2020cites this paper
• Assessment Of Stem Cell Profile In Ischemic Stroke

  2020cites this paper
• Review Article: The Prospect of Stem Cells for HIV and Cancer Treatment: A Review

  2020cites this paper
• Polycystic Ovary Syndrome (PCOS): Current and Future Therapy

  2020cites this paper
• Emerging strategies for enhancing the homing of hematopoietic stem cells to the bone marrow after transplantation.

  2020cites this paper
• Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients

  2020cites this paper
• Optimizing the recovery of peripheral blood mononuclear cells trapped in leukoreduction filters - A comparison study

  2020cites this paper
• Types and Origin of Stem Cells

  2020cites this paper
• Biomimetics for treatment of endometrial pathologies: an overview

  2020cites this paper
• Unmanipulated haploidentical peripheral blood stem cell transplantation for patients with Philadelphia-negative acute lymphoblastic leukaemia in first complete remission

  2020cites this paper
• Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies.

  2019cites this paper
• Cellular therapies for the endometrium: An update

  2019cites this paper
• Diversity patterns in parasite populations capable for persistence and reinfection with a view towards the human cytomegalovirus

  2019influential citation
• G-CSF-mobilized blood and bone marrow grafts as the source of stem cells for HLA-identical sibling transplantation in patients with thalassemia major.

  2019cites this paper
• CD34+ Stem Cells: Promising Roles in Cardiac Repair and Regeneration.

  2019cites this paper
• The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine

  2019cites this paper
• Assessment of Immune Reconstitution Following Hematopoietic Stem Cell Transplantation

  2019cites this paper
• Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources

  2019cites this paper
• Evaluation of the Sysmex XN automated hematopoietic progenitor cell enumeration for timing of peripheral blood stem cell harvest.

  2019cites this paper
• Comparable Outcomes of Allogeneic Peripheral Blood versus Bone Marrow Hematopoietic Stem Cell Transplantation in Major Thalassemia: A Multivariate Long-Term Cohort Analysis.

  2019cites this paper
• [Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors].

  2019cites this paper
• CD133+ bone marrow stem cells (BMSC) control platelet activation - Role of ectoNTPDase-1 (CD39).

  2019cites this paper
• The physical microenvironment of hematopoietic stem cells and its emerging roles in engineering applications

  2019cites this paper
• ABO-mismatched marrow processing for transplantation: Comparative results of 80 procedures performed with Cobe Spectra and Spectra Optia.

  2019cites this paper
• Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34+ Cell and Platelet Counts.

  2019cites this paper
• Using Mesenchymal Stem Cells to Treat Female Infertility: An Update on Female Reproductive Diseases

  2019cites this paper
• Penelitian Peripheral Blood Mesenchymal Stem Cells Isolated from Indonesia Long Tailed Monkey ( Macaca fascicularis )

  2018cites this paper
• Isolation and characterisation of Mesenchymal Stem Cells from Human Peripheral Blood

  2018cites this paper
• Current approaches in biomaterial-based hematopoietic stem cell niches.

  2018cites this paper
• Mass Cytometry for the Assessment of Immune Reconstitution After Hematopoietic Stem Cell Transplantation

  2018cites this paper
• Lung transplantation after allogeneic stem cell transplantation: a pan-European experience

  2018cites this paper
• Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.

  2018cites this paper
• Anti-thymocyte globulin’s activity against acute myeloid leukemia stem cells

  2018cites this paper
• Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies

  2018cites this paper
• Hematopoietic Stem Cell and Fibroblast Proliferation Following Platelet Electrostimulation

  2018cites this paper
• Stem cells and heart disease - Brake or accelerator?

  2017cites this paper
• Stem Cell Mobilization and Harvesting Failure in Case of Heavily Pretreated Patients

  2017cites this paper
• Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration

  2017cites this paper
• Cord blood as a potential therapeutic for amyotrophic lateral sclerosis

  2017cites this paper
• Managing Stem Cell Apheresis Effectively Haematopoietic stem cell transplantation

  2017cites this paper
• Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability

  2017cites this paper
• Predictors for successful PBSC collection on the fourth day of G‐CSF‐induced mobilization in allogeneic stem cell donors

  2017cites this paper
• More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working Party

  2017cites this paper
• 11 Sources of Hematopoietic Stem Cells

  2017cites this paper
• Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation.

  2017cites this paper
• Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study.

  2017cites this paper
• Development of novel therapies for Diamond-Blackfan Anemia

  2017cites this paper
• Hematopoietic cell transplantation for aplastic anemia

  2017cites this paper
• Overview of Hematopoietic Cell Transplantation

  2017cites this paper
• Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL.

  2017cites this paper
• Erythropoietin induces production of hepatocyte growth factor from bone marrow mesenchymal stem cells in vitro.

  2017cites this paper
• Role of Ultrasound in Complications of Hematopoetic Stem Cell Transplantation

  2016cites this paper
• Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood?

  2016cites this paper
• Engineering hematopoietic stem cells toward a functional cure of human immunodeficiency virus infection.

  2016cites this paper
• Multifunctional nanoparticle-based approaches to enhance the treatment of cancer

  2016cites this paper
• Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning.

  2016cites this paper
• Advances in haploidentical stem cell transplantation for hematologic malignancies

  2016cites this paper
• Engineering Stem Cells for Biomedical Applications

  2016cites this paper
• Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.

  2016influential citation
• Human bone marrow processing using a new continuous‐flow cell separation device

  2016cites this paper
• Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML

  2016cites this paper